Analisi e valutazione di una NDA per la sicurezza e la efficacia del trazodone : Hearing svoltosi il 5 marzo 1979. Parklane Building 5600 Fishers Lane Rockeville Maryland / Psychopharmacological Drugs Advisory Committee, Department of Health, Education, and Welfare ; traduttore Dr. Angelo Carta.

  • United States. Department of Health, Education, and Welfare. Psychopharmacological Drugs Advisory Committee
Date:
1981
Catalogue details

Licence: Public Domain Mark

Credit: Analisi e valutazione di una NDA per la sicurezza e la efficacia del trazodone : Hearing svoltosi il 5 marzo 1979. Parklane Building 5600 Fishers Lane Rockeville Maryland / Psychopharmacological Drugs Advisory Committee, Department of Health, Education, and Welfare ; traduttore Dr. Angelo Carta. Source: Wellcome Collection.

    13/216 (page 11)
    Dr. KARTZINEL: Ron Kartzinel, ED.A. Dr. CAMP: Sono Bonnie Camp. Anche i nostri Ospiti sono pregati di presentarsi. Cominciamo da Léi. Dr. PERHACH: Jim Perhach, Mead Johnson Dr. RIBLET: Les Riblet, Mead Johnson Dr ORLANDO: Tony Orlando, Mead Johnson Ms. GUNTHER: Barbara Gunther, Mead Johnson Dr. FEIGHNER, Dr. John Feighner, Centro Psichiatrico di San Diego Dr. NEWTON: Dr, Newton, Mead Jonhson Dr. GERSHON: Sam Gershon, NYU Dr. MAJEWSKI: Bob Majewski, Mead Johnson Mr. DAVIS: David Davis, FDA Mr. HOLLAND, Bob Holland, FDA Mr. BARLENCAMP: Dan BARLENCAMP, Hoffman Roche Mr. KASIN: Joe Kasin, SAF Mr. FISHER: Alan Fisher . Mr TOMLINSON: John Tomlinson, Laboratori Abbott Ms. SMITH: Betty Smith Mr. EATON: Mr. Eaton, Sandoz Mr. COLE: Jim Cole, FDA Mr. WEAVER: Paul Weaver, FDA Mr. HERBERT: Al Herbert, Mead Johnson Ms. WOO: Ms. Woo, FDA Mr. SISSON: George Sisson, Mead Johnson Dr. WORRALL: Paul Worrall, Mead Johnson Dr. CAMP: mi sembra di aver capito che non ci sono dichiarazioni, per cui possiamo proseguire e passare . all'esame del trazodone. I drri Majewski e Newton ne fanno la presentazione per la loro società. Dr. KARTZINEL: Ron Kartzinel, FDA. Dr. CAMP: | am Bonnie Camp. Maybe we could also have our visitors introduce themselves. Let's start with you. Dr. PERHACH: Jim Perhach, Mead Johnson. Dr. RIBLET: Les Riblet, Mead Johnson. Dr. ORLANDO: Tony Orlando, Mead Johnson. Ms. GUNTER: Barbara Gunther, Mead Johnson. Dr. FEIGHNER: Dr. John Feighner, Psychiatry Center in San Diego. Dr. NEWTON: Dr. Newton, Mead Johnson. Dr. GERSHON: Sam Gershon, NYU. Dr. MAJEWSKI: Bob Majewski, Mead Johnson. Mr. DAVIS: David Davis, FDA. Mr. HOLLAND: Bob Holland, FDA. Mr. BARLENCAMP: Dan Barlencamp, Hoffman Roche. Mr. KASIN: Joe Kasin, SAF. Mr. FISHER: Alan Fisher. Mr. TOMLINSON: John Tomlinson, Abbott Laboratories. Ms. SMITH: Betty Smith. Mr. EATON: Mr. Eaton, Sandoz. Mr. COLE, Jim Cole, FDA. Mr. WEAVER: Paul Weaver, FDA. Mr. HERBERT: Al Herbert, Mead Johnson. Ms. WOO: Ms. Woo, FDA. Mr. SISSON: George Sisson, Mead Johnson. Dr. WORRALL: Paul Worrall, Mead Johnson. Dr. CAMP: | understand there are no announcements. Is that correct? So | believe we can go ahead and start witha review of trazodone. | believe Dr. Majewski and Dr. Newton are going to present for the company. Il